EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

André Fienemann iD, Theresa Lüth iD, Susen Schaake, Carolin Gabbert iD, Marius Möller, Hauke Busch, Katja Lohmann, Jonas A Gustafson, Danny E Miller, Kensuke Daida iD, Manabu Funayama, Nobutaka Hattori und 6 weitere

Annals of Clinical and Translational Neurology · 2026-07 · 13 (7) · 1467-1481

DOI: 10.1002/acn3.70332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 07.02.2026. Verfasst von André Fienemann und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurogenetics, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, Genomic Structural Variation, Chromosome Mapping, Nanopore Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.

Methods

Ultra‐high molecular weight DNA was derived from blood and fibroblast cultures of 19 patients with mostly early‐onset Parkinson's disease, and used for Nanopore sequencing and optical genome mapping. The size distributions of deletions and insertions were compared, and variants were filtered for rare or potentially pathogenic variants in 134 known movement disorder genes.

Results

Both methods identified SVs > 50 kb; however, optical mapping identified fewer structural variants (49,677) compared to Nanopore sequencing (94,400), but detected six times more in the range 50–80 kb. In general, it detected significantly larger deletions and insertions ( p < 2.2 × 10 −16 ). Both methods detected a benign intergenic deletion (195 kb) near ITPR1 , and optical mapping validated a previously published 7‐Mb PRKN inversion. Small heterozygous deletions in ATXN2 , SUCLA2 , and PNKD detected by optical mapping were identified to be intronic by Nanopore sequencing. No causal variants were identified in movement disorder genes.

Interpretation

Optical mapping can be a powerful first‐line method for detecting large structural variants, but it requires a high‐resolution method to refine breakpoint positions. Despite certain limitations, Nanopore sequencing was highly capable of detecting large variants independently and allows for a highly complementary assessment and validation of structural variation in combination with optical mapping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGenomic Structural VariationChromosome MappingNanopore SequencingHumansMaleFemaleMiddle Aged

Stichwörter der Autor:innen

Parkinson's diseasenanopore long‐read sequencingoptical genome mappingstructural variants

Autor:innen und Institutionen

  • Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Division of Genetic Medicine, Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
  • Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, USA.

ORCID-Profile: André Fienemann, Theresa Lüth, Carolin Gabbert, Kensuke Daida, Matthew J Farrer

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

Zitieren

APA

Fienemann, A., Lüth, T., Schaake, S., Gabbert, C., Möller, M., Busch, H., Lohmann, K., Gustafson, J. A., Miller, D. E., Daida, K., Funayama, M., Hattori, N., Sassi, S. B., Hentati, F., Farrer, M. J., Ullrich, K. K., Klein, C., & Trinh, J. (2026). Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants. Annals of Clinical and Translational Neurology, 13(7), 1467-1481. https://doi.org/10.1002/acn3.70332

Vancouver

Fienemann A, Lüth T, Schaake S, Gabbert C, Möller M, Busch H, et al. Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants. Annals of Clinical and Translational Neurology. 2026;13(7):1467-1481. doi:10.1002/acn3.70332

BibTeX
@article{Fienemann2026,
  author = {Fienemann, André and Lüth, Theresa and Schaake, Susen and Gabbert, Carolin and Möller, Marius and Busch, Hauke and Lohmann, Katja and Gustafson, Jonas A and Miller, Danny E and Daida, Kensuke and Funayama, Manabu and Hattori, Nobutaka and Sassi, Samia Ben and Hentati, Faycel and Farrer, Matthew J and Ullrich, Kristian K and Klein, Christine and Trinh, Joanne},
  title = {Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {1467--1481},
  doi = {10.1002/acn3.70332}
}
Kostenlos starten →